Home/Filings/4/0000899243-17-008531
4//SEC Filing

CYNOSURE INC 4

Accession 0000899243-17-008531

CIK 0000885306operating

Filed

Mar 23, 8:00 PM ET

Accepted

Mar 24, 4:45 PM ET

Size

27.8 KB

Accession

0000899243-17-008531

Insider Transaction Report

Form 4
Period: 2017-03-22
Transactions
  • Disposition to Issuer

    Stock Option (right to purchase)

    2017-03-225,0000 total
    Exercise: $8.40Exp: 2018-11-14Class A Common Stock (5,000 underlying)
  • Disposition to Issuer

    Stock Option (right to purchase)

    2017-03-226,0000 total
    Exercise: $13.60Exp: 2020-05-12Class A Common Stock (6,000 underlying)
  • Disposition to Issuer

    Stock Option (right to purchase)

    2017-03-226,0000 total
    Exercise: $13.97Exp: 2021-05-12Class A Common Stock (6,000 underlying)
  • Disposition to Issuer

    Stock Option (right to purchase)

    2017-03-225,2440 total
    Exercise: $35.37Exp: 2025-05-14Class A Common Stock (5,244 underlying)
  • Disposition to Issuer

    Stock Option (right to purchase)

    2017-03-222,0000 total
    Exercise: $11.89Exp: 2021-07-27Class A Common Stock (2,000 underlying)
  • Disposition to Issuer

    Stock Option (right to purchase)

    2017-03-228,0000 total
    Exercise: $23.45Exp: 2023-06-24Class A Common Stock (8,000 underlying)
  • Disposition from Tender

    Class A Common Stock

    2017-03-22$66.00/sh18,850$1,244,1000 total
  • Disposition to Issuer

    Stock Option (right to purchase)

    2017-03-226,0000 total
    Exercise: $7.24Exp: 2019-05-13Class A Common Stock (6,000 underlying)
  • Disposition to Issuer

    Stock Option (right to purchase)

    2017-03-228,0000 total
    Exercise: $21.16Exp: 2022-05-09Class A Common Stock (8,000 underlying)
  • Disposition to Issuer

    Stock Option (right to purchase)

    2017-03-2210,6480 total
    Exercise: $21.11Exp: 2024-05-14Class A Common Stock (10,648 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2017-03-221,2720 total
    Exp: 2026-05-11Class A Common Stock (1,272 underlying)
Footnotes (4)
  • [F1]Pursuant to the terms of that certain Agreement and Plan of Merger, dated as of February 14, 2017, by and among Hologic, Inc., Minuteman Merger Sub, Inc. and Cynosure, Inc. (the "Merger Agreement"), these shares were tendered and disposed of at the Acceptance Time (all terms capitalized but not defined shall have the meaning given to them in the Merger Agreement) in exchange for the right to receive $66.00 per share, net to the seller in cash, without interest, less any required withholding taxes (the "Merger Consideration").
  • [F2]This stock option was fully vested and exercisable prior to the Effective Time. Pursuant to the terms of the Merger Agreement, each outstanding and unexercised stock option as of immediately prior to the Effective Time, whether vested or unvested, was automatically canceled and converted into the right to receive, for each underlying share, the difference between the Merger Consideration and the exercise price per share of the option.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of Cynosure, Inc.'s common stock.
  • [F4]Pursuant to the terms of the Merger Agreement, each outstanding and unvested restricted stock unit as of immediately prior to the Effective Time vested in full and was automatically canceled and converted into the right to receive the Merger Consideration for each underlying share.

Issuer

CYNOSURE INC

CIK 0000885306

Entity typeoperating

Related Parties

1
  • filerCIK 0000885306

Filing Metadata

Form type
4
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 4:45 PM ET
Size
27.8 KB